Goldman Sachs cuts Nanobiotix stake to 3.78%
NBTX•Goldman Sachs reduces Nanobiotix holding below 5%
Goldman Sachs cut its stake in Nanobiotix below 5% on Aug. 24.
Holding fell to 1,921,176 shares, equal to 3.78% of share capital and 3.52% of voting rights.
The move followed an off-market sale of shares.
The position includes 1,478,840 shares via 17 cash-settled swap contracts, exercisable through Aug. 20, 2036.
